首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   252593篇
  免费   13036篇
  国内免费   421篇
耳鼻咽喉   3232篇
儿科学   7982篇
妇产科学   5347篇
基础医学   36112篇
口腔科学   5547篇
临床医学   20941篇
内科学   55035篇
皮肤病学   6528篇
神经病学   23144篇
特种医学   7382篇
外国民族医学   101篇
外科学   30811篇
综合类   1180篇
现状与发展   1篇
一般理论   83篇
预防医学   24099篇
眼科学   4758篇
药学   17627篇
  1篇
中国医学   719篇
肿瘤学   15420篇
  2023年   1467篇
  2022年   1206篇
  2021年   4215篇
  2020年   2529篇
  2019年   4563篇
  2018年   8184篇
  2017年   5461篇
  2016年   5513篇
  2015年   6085篇
  2014年   6455篇
  2013年   10389篇
  2012年   17716篇
  2011年   17650篇
  2010年   8778篇
  2009年   6634篇
  2008年   14868篇
  2007年   15930篇
  2006年   14621篇
  2005年   14406篇
  2004年   13496篇
  2003年   12252篇
  2002年   11613篇
  2001年   6254篇
  2000年   6330篇
  1999年   5648篇
  1998年   1027篇
  1997年   848篇
  1996年   783篇
  1995年   714篇
  1992年   3247篇
  1991年   2907篇
  1990年   2757篇
  1989年   2528篇
  1988年   2400篇
  1987年   2231篇
  1986年   2134篇
  1985年   1911篇
  1984年   1447篇
  1983年   1215篇
  1979年   1222篇
  1978年   864篇
  1977年   811篇
  1975年   827篇
  1974年   1002篇
  1973年   1009篇
  1972年   943篇
  1971年   932篇
  1970年   870篇
  1969年   911篇
  1968年   795篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
85.
86.
87.

Introduction

The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.

Objective

To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.

Methods

Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.

Results

A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.

Conclusion

Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality.  相似文献   
88.
89.
90.
Introduction: The rising prevalence of musculoskeletal pathologies in developed countries has caused a dramatic impact on social welfare. Amidst these musculoskeletal pathologies is Rheumatoid arthritis (RA), a chronic systemic autoimmune disease that mostly affects the synovium. RA metabolic-associated alterations, including distorted adipokine production, enhance RA inflammatory environment. Among the altered adipokines, visfatin is particularly involved in RA inflammation and catabolism and stands out as an essential enzyme linked to critical cell features.

Areas covered: We discuss the potential mechanism supporting the contribution of visfatin to RA and the association between RA and obesity. We discuss the repurposing of cancer-tested drugs to inhibit visfatin in the context of RA. Additionally, we address the possibility of combining these drugs with current RA therapy. Finally, we explore the future of visfatin as an RA biomarker or therapeutic target.

Expert opinion: Inhibition of visfatin has become an interesting therapeutic approach for RA pathology. Such a feat has already been attained in oncology using small molecule inhibitors, which suggest that a similar course of action would be worth pursuing in the RA context. Visfatin will become an important biomarker and therapeutic target for RA.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号